Inventor

Hing C. Wong

Inventor

Weston, FL, US

Overview

1987–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 57 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides24%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%

A61KPreparations for medical, dental or toiletry purposes20%

C12NMicroorganisms or enzymes13%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture7%

G01NInvestigating or analysing materials by determining their chemical or physical properties5%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%

A01KAnimal husbandry1%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

B82YSpecific uses or applications of nanostructures1%

PatentTitleYear

10,899,821Method of treating neoplasia with a multimeric IL-15 soluble fusion molecule2021 10,865,230Construction and characterization of multimeric IL-15-based molecules with CD3 binding domains2020 10,844,107HIV VPR-specific T-cell receptors2020 10,537,615IL-15-based molecules and methods of use thereof2020 10,450,359IL-15 variants and uses thereof2019 10,358,478Multimeric IL-15 soluble fusion molecules and methods of making and using same2019 10,150,805Multimeric IL-15 soluble fusion molecules and methods of making and using same2018 9,925,247'IL-15-based molecules and methods of use thereof'2018 9,714,279'HIV vpr-specific T-cell receptors'2017 9,593,152'Methods of treating disease with fusion molecules comprising IL-15 variants'2017 9,464,127'Fusion molecules and IL-15 variants'2016 9,428,573'Multimeric IL-15 soluble fusion molecules and methods of making and using same'2016 9,328,159'Multimeric IL-15 soluble fusion molecules and methods of using same'2016 9,290,560'Soluble TCR molecules and methods of use'2016 9,255,141'Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using same'2016 8,940,289'Fusion molecules and IL-15 variants'2015 8,933,198'HIV VPR-specific T cell receptors'2015 8,772,451'Soluble TCR molecules and methods of use'2014 8,507,222'Multimeric IL-15 soluble fusion molecules and methods of making and using same'2013 8,492,118'Fusion molecules and IL-15 variants'2013 8,372,958'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria'2013 8,163,879'Fusion molecules and IL-15 variants'2012 8,105,830'Polyspecific binding molecules and uses thereof'2012 8,007,795'Anti-tissue factor antibodies and methods of use thereof'2011 7,968,094'Use of anti-tissue factor antibodies for treating thromboses'2011 7,884,198'Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'2011 7,824,677'Method for using antibodies for inhibiting blood coagulation'2010 7,749,498'Antibodies for inhibiting blood coagulation and methods of use thereof'2010 7,511,122'Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria'2009 7,456,263'P53 binding T cell receptor molecules'2008 7,199,113'Pharmaceutically active compounds and methods of use thereof'2007 7,141,656'MHC complexes and uses thereof'2006 7,074,905'Soluble MHC complexes and methods of use thereof'2006 7,074,904'MHC complexes and uses thereof'2006 6,939,543'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'2005 6,849,617'Tissue factor antagonists and methods of use thereof'2005 6,828,312'Pharmaceutically active compounds and methods of use thereof'2004 6,610,293'Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria'2003 6,608,066'Tissue factor antagonists and methods of use thereof'2003 6,555,319'Antibodies for inhibiting blood coagulation and methods of use thereof'2003 6,534,633'Polyspecific binding molecules and uses thereof'2003 6,309,645'MHC molecules and uses thereof'2001 6,232,445'Soluble MHC complexes and methods of use thereof'2001 6,127,524'Binding molecules and computer-based methods of increasing the binding affinity thereof'2000 5,986,065'Antibodies for inhibiting blood coagulation and methods of use thereof'1999 5,888,775'Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof'1999 5,869,270'Single chain MHC complexes and uses thereof'1999 5,763,284'Methods for peptide synthesis and purification'1998 5,759,828'Cyclic di-guanylate metabolic enzymes'1998 5,516,637'Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage'1996 5,268,274'Methods and nucleic acid sequences for the expression of the cellulose synthase operon'1993 D0342103'Puzzle'1993 5,164,305'Streptomyces promoter and method of use thereof'1992 4,952,508'Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis'1990 4,910,141'3\'-expression enhancing fragments and method'1990 4,792,523'3\'Expression enhancing fragments and method'1988 4,666,848'Polypeptide expression using a portable temperature sensitive control cassette with a positive retroregulatory element'1987

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1987–1998Based in San Ramon, CA, US· patent location history

1993–2016Patents assigned to WONG HING C (10)· patent assignee history

1993Based in Honolulu, HI, US· patent location history

1996–2011Based in Fort Lauderdale, FL, US· patent location history

1999–2005Patents assigned to SUNOL MOLECULAR CORP (10)· patent assignee history

2003–2020Patents assigned to ALTOR BIOSCIENCE CORP (25)· patent assignee history

2003–2021Based in Weston, FL, US· patent location history

2012–2016Patents assigned to ZHU XIAOYUN (6)· patent assignee history

2018–2021Patents assigned to ALTOR BIOSCIENCE LLC (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
ALTOR BIOSCIENCE CORP	25	2003–2020
SUNOL MOLECULAR CORP	10	1999–2005
WONG HING Cself	10	1993–2016
ZHU XIAOYUN	6	2012–2016
ALTOR BIOSCIENCE LLC	5	2018–2021

Locations

Location	Patents	Span
Weston, Florida, US	34	2003–2021
Fort Lauderdale, Florida, US	15	1996–2011
San Ramon, California, US	7	1987–1998
Honolulu, HI, US	1	1993